Arash Farahvar, MD
Neurological Surgery · Venice, FLNPI 1659382679
Payments from drug & device makers
What this record shows
Globus Medical accounts for 67.5% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $2,111, 7.1 times the $297 reported in 2019. That places this record below the midpoint for neurological surgery clinicians in FL, where the typical reported total is $5,245.
Across 80 payments — averaging $36.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$2K
- Nevro Corp.$220
- Medtronic$171
- Boston Scientific$150
- Surgalign Spine Technologies, Inc.$116
- GE HealthCare$75
- plus $221 from 8 others
What the payments were for
- Travel & lodging$1,63956%
- Food & beverage$1,29544%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 33 | $1,981 |
| Nevro Corp. | 16 | $220 |
| Medtronic(2 entities) | 9 | $171 |
| Boston Scientific | 4 | $150 |
| Surgalign Spine Technologies, Inc. | 5 | $116 |
| GE HealthCare | 3 | $75 |
| Johnson & Johnson(2 entities) | 2 | $42 |
| Orthofix Medical, Inc. | 1 | $42 |
| Integra Lifesciences Corporation | 2 | $39 |
| Aesculap, Inc. | 1 | $28 |
| Ceribell, Inc. | 1 | $25 |
| AstraZeneca | 1 | $22 |
| Stimwave Technologies Incorporated | 1 | $13 |
| Vertos Medical, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FORTIFY$1,491
How this compares
$2,934 in reported general payments places this provider in the 40th percentile of 556 neurological surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 52 | $14,286 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 525 | $5,761 |
| Dexamethasone | 466 | $3,723 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 223 | $2,239 |
| Methocarbamol | 170 | $1,665 |
| Oxycodone Hcl | 148 | $900 |
| Pregabalin | 48 | $721 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 15 | $671 |
| Diazepam | 176 | $559 |
| Tramadol Hcl | 98 | $380 |
| Gabapentin | 25 | $225 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 48 | $207 |
| Hydromorphone Hcl | 30 | $130 |
| Cyclobenzaprine Hcl | 17 | $87 |
| Cephalexin | 20 | $84 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Venice
- Stephen ParkerJacksonville$18.7M
- Eric PetersonMiami$10.1M
- Brian SnellingBoca Raton$10M
- Kim ManwaringOrlando$5M
- Paul SawinWinter Park$3M
- John MainOcala$2.8M
- Michael WangMiami$2.2M
- Andrew CannestraJacksonville$1.6M
- Rohit VasanTampa$1.5M
- Wilson AsforaMiami$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.